Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege
about
Targeting the indoleamine 2,3-dioxygenase pathway in cancerAnti-inflammatory therapy in chronic disease: challenges and opportunitiesMetabolic reprogramming and metabolic dependency in T cellsRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseKynurenines in the mammalian brain: when physiology meets pathologyCytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNAPsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorHigh-throughput sequencing reveals key genes and immune homeostatic pathways activated in myeloid dendritic cells by Porphyromonas gingivalis 381 and its fimbrial mutants.Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cellsHalofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetesIDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionThe therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosisMHC molecules in health and disease: At the cusp of a paradigm shift.Underweight full-term Indian neonates show differences in umbilical cord blood leukocyte phenotype: a cross-sectional study.The immunobiology of the mammalian epididymis: the black box is now open!Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formationRecent developments on immunotherapy for brain cancer.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7.Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes.Placental expression of indoleamine 2,3-dioxygenase.Indoleamine 2,3-dioxygenase: from catalyst to signaling function.Metabolic checkpoints in activated T cells.STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?Signal Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3 Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1.Is Immune Modulation the Mechanism Underlying the Beneficial Effects of Amniotic Cells and Their Derivatives in Regenerative Medicine?Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.Good news-bad news: the Yin and Yang of immune privilege in the eye.Pancreatic islet transplants and IDO: when starving the enemy does you goodThe immune diet: meeting the metabolic demands of lymphocyte activation.Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment.The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus.CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes.
P2860
Q26775471-20B22C3C-5623-4CB5-A302-03F43F61263BQ26860162-37B9F187-685E-4D7C-A29F-E436D8C8418EQ26864319-1F539695-3820-4320-B2F3-2E9A666E2E47Q26996330-A840BA02-8F53-4840-B57B-AC10985324F7Q27003296-D82C18EF-3CC5-4F2C-8E34-9EA1D3ECBBC4Q27022855-9D865A0E-71A7-4EB0-9182-9585DF3FEADEQ27694728-28546B0B-9E94-44B6-AE7C-CC81D8654596Q33841965-1631C7D0-EA23-4402-9646-EB90ADCA098AQ34110557-EC3D235B-97B5-456D-9C37-791D6B099C44Q34253805-A616B438-6133-4FFC-8D14-8C22D461270FQ34323684-8B690746-80A2-49B9-9BBB-D6ADEDA51DF7Q34396547-AF0CF5B3-CF20-4CC9-AB68-CB51201B5C75Q34438046-120D98EB-907E-405E-9F81-9DE89B79FABAQ34778943-FC1D15BD-15EB-45CC-8AD6-E0E2D6D1FF4CQ35016997-975F7870-0135-412B-8F5A-2CE7CCE5A354Q35107011-6B6625BF-0826-4241-94AF-29419CC74EC6Q35512854-CB662C28-444C-4AC3-86A4-F4B0A10D3AB0Q35579203-26B6B32D-3DA2-4CBD-9D3C-A5A1A333DF58Q35624272-9C7F7736-EF57-4846-AE7D-4D8FBD668837Q35949475-35880265-ED13-4235-9101-6B529F001FDEQ35986384-1EF7FE6D-5EC0-4742-AFC6-1D35F5A157ADQ35992355-7A29884D-4A1D-4224-8CAA-E4F4994A6A2EQ37089253-548EA549-77EB-44EF-AD8B-646BA7697C0FQ37188781-A301B63B-54CB-4712-BFF0-0D9F05F65168Q37711667-8659D6AB-8BBF-4C1C-BE07-12D9B2B2B5BCQ37820820-8C5C8A43-626A-428E-B003-0523D0594F79Q38020356-ABF5AD86-8314-4FF9-B447-24DE4C5C370EQ38032201-2DC027ED-D56A-4A73-B431-18C3E3FAA87EQ38044664-64DD46B6-9B9A-44BF-90B7-A0B537059D31Q38293111-D322A469-191A-4CE8-86CE-8D021EF455CDQ38725391-582B73B7-5C87-4224-A8C6-DC6CE3248718Q39034662-98A604A6-F3D7-4679-9CED-5B1AAEF74B6BQ39727068-3A1C1681-B689-402C-B50A-D2B3EEC387E8Q40495763-AA4CF83C-AD52-4270-8D21-82FE359209CDQ41780299-C54DE5EA-793D-4733-A7B6-3B3299BB8203Q41889772-B997ADCB-D338-47CA-8ADB-F66D107EC80AQ41898658-B1003AC2-00A2-426A-BFBB-CF7276E326BEQ42000663-29C9B37E-A4D6-423E-87BA-AF7EF982ECCFQ42339159-BAC7C91B-C35E-410B-955D-C51059C096D9Q42490694-2C8D6C86-2C56-47F8-8B25-AA45A652E2C1
P2860
Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege
@en
type
label
Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege
@en
prefLabel
Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege
@en
P2093
P2860
P1476
Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege
@en
P2093
Andrew L Mellor
Babak Baban
Burles A Johnson
P2860
P304
P356
10.3109/08830180903349669
P577
2010-04-01T00:00:00Z